Bio Medica Laboratories
- Company typePrivate
- Founded2005
- HeadquartersIndore, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Bio Medica Laboratories firmographics
Firmographics- Name
- Bio Medica Laboratories
- Legal name
- BIO MEDICA LABORATORIES LIMITED
- Website
- https://biomedica.co.in
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Bio Medica Laboratories industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Bio Medica Laboratories is headquartered
LocationHeadquarters
- HQ city
- Indore
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Bio Medica Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Injectables Manufacturing and Sales: Manufactures and sells a wide range of injectable formulations for domestic, international export, and veterinary markets. Revenue generated through product sales to healthcare providers, pharmaceutical distributors, and institutions. The company also offers contract manufacturing services leveraging advanced facilities and expertise.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Bio Medica Laboratories product offering
Product offeringCore offering
BIO MEDICA LABORATORIES LIMITED manufactures and sells a wide range of parenteral (injectable) pharmaceutical formulations for the Indian domestic market, international export markets, and veterinary use. The company operates GMP and GLP-compliant production facilities in Indore, Madhya Pradesh, producing sterile solutions, antibiotics, vitamins, analgesics, and critical care injectables, and additionally offers contract manufacturing, formulation development, and loan licensed manufacturing services to pharmaceutical partners.
Product overview
BIO MEDICA LABORATORIES LIMITED is a prominent parenteral manufacturer in Central India producing a diverse range of injectable formulations. The company operates three core product lines: Injectables for Domestic Market (over 50 formulations including diclofenac sodium, vitamin B-complex, multivitamin, antibiotics, and specialty injectables), Injectables for Export (international-grade formulations including meropenem, vancomycin, ceftriaxone), and Injectables for Veterinary Use (animal health injectables including oxytetracycline, atropine, meloxicam). Supporting services include Contract Manufacturing (custom formulation development and loan licensed manufacturing), Quality Assurance, and Research and Development. All operations adhere to GMP and GLP standards with facilities in Indore, Madhya Pradesh.
Differentiator
Problem solved
Functional benefit
Products and services
- Injectables for Domestic Market Wide range of injectable formulations for the Indian domestic market including diclofenac sodium, vitamin B-complex, multivitamin, antibiotics (amikacin, meropenem, ceftriaxone), and various specialty injectables for pain management, anesthesia, and critical care, targeting hospitals, clinics, and healthcare institutions across India.
- Injectables for Export Injectable formulations exported internationally adhering to global quality standards including omeprazole, artesunate, meropenem, imipenem, co-amoxiclav, ceftriaxone, vancomycin, and other specialty injectables, supplied to international pharmaceutical distributors and healthcare institutions worldwide.
- Injectables for Veterinary Specialized injectable formulations for veterinary use addressing animal health needs including oxytetracycline, atropine sulphate, sulphadimidine, meloxicam, ceftiofur, aceclofenac, and vancomycin, targeted at veterinary clinics, animal healthcare providers, and livestock management operations.
- Contract Manufacturing Services Contract manufacturing services leveraging advanced GMP and GLP-compliant facilities and expertise to produce custom parenteral formulations for pharmaceutical partners, including formulation development and loan licensed manufacturing.
Companies that use Bio Medica Laboratories
Customer profileSegments4 records
Ideal customer profiles4 records
Bio Medica Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Bio Medica Laboratories partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Bio Medica Laboratories competitors and assessment
Company assessmentBroad incumbents
- Dr. Reddy's Laboratories: Large Indian generic pharmaceutical manufacturer with a strong injectables franchise (meropenem, vancomycin, ceftriaxone) targeting regulated and emerging markets. Direct overlap with BML's export portfolio molecules, though operating at a global scale with USFDA-approved facilities.
- Cipla: Major Indian pharmaceutical company with a domestic and export injectables portfolio covering antibiotics, oncology, and critical care. Overlaps with BML on commodity injectable generics and contract manufacturing, though at significantly larger scale and broader therapeutic breadth.
- Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with a substantial injectable formulations business (AuroMedics) serving US and global markets. Competes with BML in generic injectables but operates at vastly larger scale across multiple dosage forms and geographies.
- Zydus Lifesciences (Cadila): Major Indian pharmaceutical group with injectable manufacturing across human and animal health segments. Comparable through its injectable formulations portfolio and contract manufacturing services, though at substantially larger scale and broader geographic reach.
Direct peers
- Neon Laboratories: India-based injectable-focused pharmaceutical manufacturer with a domestic and export portfolio of sterile small-molecule formulations. Most directly comparable to BML in product mix (analgesics, antibiotics, critical care injectables) and scale of operations targeting institutional and contract manufacturing customers.
- Alpa Laboratories: Indian manufacturer of sterile injectable formulations (small and large volume parenterals) with domestic and emerging-market exports. Closely matches BML's product mix, scale, and Indore-style mid-tier Indian injectable manufacturer profile.
- Mercury Laboratories: Indian pharmaceutical manufacturer specializing in sterile injectables and small-volume parenterals. Competes with BML in domestic institutional sales and contract manufacturing, with a similarly diversified product base.
- Lyka Labs: Indian sterile injectables manufacturer with a comparable portfolio of human and veterinary parenteral products. Similar mid-tier scale, GMP manufacturing footprint, and B2B distribution to hospitals, institutions, and export markets, making it a closely matched Indian peer.
- Bharat Serums and Vaccines: Indian specialty injectables and biologicals manufacturer (now part of Mankind Pharma) operating in critical care, gynecology, and veterinary segments. Highly comparable to BML's critical-care and veterinary injectable portfolio, though larger and more biologics-focused.
Regional players
- TTK Healthcare: Indian healthcare group with pharmaceutical manufacturing operations including injectables, animal health, and consumer products. Comparable through its animal-health injectables and India-focused manufacturing model, though it operates at larger scale and with broader diversification.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bio Medica Laboratories social profiles
Digital presenceBio Medica Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bio Medica Laboratories leadership team
Management profileNumber of profiles
Profiles5 records
Bio Medica Laboratories subsidiaries and ownership
Company hierarchySubsidiaries3 records
Bio Medica Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bio Medica Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bio Medica Laboratories
What does Bio Medica Laboratories do?
BIO MEDICA LABORATORIES LIMITED manufactures and sells a wide range of parenteral (injectable) pharmaceutical formulations for the Indian domestic market, international export markets, and veterinary use. The company operates GMP and GLP-compliant production facilities in Indore, Madhya Pradesh, producing sterile solutions, antibiotics, vitamins, analgesics, and critical care injectables, and additionally offers contract manufacturing, formulation development, and loan licensed manufacturing services to pharmaceutical partners.
Is Bio Medica Laboratories a public or private company?
Bio Medica Laboratories is a private company. It is classified as public and is currently operating.
When was Bio Medica Laboratories founded?
Bio Medica Laboratories was founded in 2005. It employs 11 to 50 people.
Where is Bio Medica Laboratories based?
Bio Medica Laboratories is headquartered in Indore, India, in the Asia region.
How does Bio Medica Laboratories make money?
One revenue line is on record: pharmaceutical Injectables Manufacturing and Sales.
Who are Bio Medica Laboratories's main competitors?
Broad incumbents on record are Dr. Reddy's Laboratories, Cipla, Aurobindo Pharma and Zydus Lifesciences (Cadila). Direct peers are Neon Laboratories, Alpa Laboratories, Mercury Laboratories, Lyka Labs and Bharat Serums and Vaccines. TTK Healthcare is listed as a regional player.
Does Bio Medica Laboratories have an API?
No public API is recorded for Bio Medica Laboratories.
What industry is Bio Medica Laboratories in?
Bio Medica Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.